Preclinical development of orally available sphingosine kinase inhibitors

e14615 Background: Sphingolipid-metabolizing enzymes control the dynamic balance of important bioactive lipids, including apoptotic ceramide and proliferative sphingosine 1-phosphate (S1P). Several...